NYSE:DOCS

24.63
0.19 (0.77%) 1d
0
Investor Insights

This summary was created by AI, based on 1 opinions in the last 12 months.

Doximity (DOCS-N) has seen a significant increase of 38% since its IPO in fall 2021 after suffering losses due to inflation and rate hikes. The company has shown signs of recovery and has consistently beaten market expectations. However, the delay in their new telemedicine product due to regulatory interference has affected their guidance. With a high PE ratio of 47x for 2023, the stock is considered pricey, although it remains profitable.

Consensus
Mixed
Valuation
Fair Value
COMMENT
Doximity

Up 38% since IPO in fall 2021. Shares got killed last year during inflation and rate hikes. Has since rebounded. It's been a round trip. Their last report was solid, but guidance was ugly, given a delay in their new telemedicine product given regulatory interference. But they've beaten every quarter. Pricey at 47x PE 2023 but are profitable.

Healthcare
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Doximity(DOCS-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Doximity is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Doximity(DOCS-N) Frequently Asked Questions

What is Doximity stock symbol?

Doximity is a American stock, trading under the symbol DOCS-N on the New York Stock Exchange (DOCS). It is usually referred to as NYSE:DOCS or DOCS-N

Is Doximity a buy or a sell?

In the last year, there was no coverage of Doximity published on Stockchase.

Is Doximity a good investment or a top pick?

Doximity was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Doximity.

Why is Doximity stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Doximity worth watching?

In the last year, there was no coverage of Doximity published on Stockchase.

What is Doximity stock price?

On 2024-04-19, Doximity (DOCS-N) stock closed at a price of $24.63.